(Diagnosed Related Groups) system is based on the calculation of average costs for patient
treatment and the system rewards efficiency. Consequently we gain on the treatment of
patients receiving anticoagulation treatment while at the same time CSO/Anticoagulation helps us to reduce our consumption of resources.
Ivan Brandslund, Laboratory Director, Consultant, DMSc, Vejle Hospital, Denmark